CLINICAL ROLE -
FDA Approves First Drug for Tardive Dyskinesia
The FDA has approved valbenazine (Ingrezza, Neurocrine Biosciences Inc.) capsules, the first drug approved to treat adults with tardive dyskinesia.
Read More
Continuing Education Opportunities Highlight Asembia Specialty Pharmacy Summit
Attendees at the 2017 Asembia Specialty Pharmacy Summit will feature a robust lineup of sessions to obtain pharmacy CE credits.
Novel Approach May Revolutionize Creation of HIV Vaccine
Determining the composition of HIV’s glycoprotein can help fight the virus.
Bill Introduced in Congress Seeks to Improve Pharmacy Access in Underserved Areas
Legislation would allow community pharmacies to participate in Part D networks if they accept regulations and conditions that other in-network pharmacies operate within.
Lawmakers Continue to Challenge PBMs Through Legislation
Sen Ron Wyden (D-OR) introduced the C-THRU Act to regulate pharmacy benefit managers.
New Legislation Would Increase Access to Community Pharmacies
HR 1939 would allow community pharmacies to participate in Part D plans.
Dietary Supplements May Not Improve Cardiovascular Health
Long-term multivitamin use not found to reduce the risk of cardiovascular events or mortality.
Novel Molecule May Provide Targeted Treatment for Advanced Prostate Cancer
Selective androgen receptor degraders show promise as treatment for castration-resistant prostate cancer.
Researchers Note Tigecycline-Resistant Human Pathogens in Dogs
Spanish researchers have documented the first example of tigecycline-resistant bacteria adapted to living on companion animals through a study that analyzed bacteria isolated from dogs at a veterinary hospital.
Biogen Wins Patent Dispute for Multiple Sclerosis Drug Tecfidera
Under the ruling, Biogen secured Tecfidera exclusivity through 2028.
Trending News Today: Risk From Thyroid Cancer Could be Underestimated
Top news of the day from across the health care landscape.
NIH Grants Lead to Overwhelming Number of Private Sector Biomedical Patents
Thirty-one percent of NIH grants have been cited in biomedical patents.
Certain Immune Cells Play Crucial Role in Immunotherapy Response, Study Suggests
Findings may explain why some patients with cancer respond to immunotherapy while others do not.
First Sign of Dementia Observed to be Abnormal Synaptic Connections
Brain tissue death may not be the first symptom of dementia.
Medicinal Diet May Protect Against Type 1 Diabetes
Eating digestion resistant starches observed to prevent diabetes.
SGLT2 Inhibitors: Little Information on Use in African Americans
The journal Postgraduate Medicine has published a new article that examines the use of SGLT2 inhibitors in the African American population.
Pediatric Transition Care Needs Improvement
Study finds pediatric patients can benefit from improved discharge medication services transitioning from hospital to home.
Trending News Today: Lawmakers Clash Over ACA Insurer Subsidies
Top news of the day from across the healthcare landscape.
Medicare Advantage, Part D Programs Finalized for 2018
CMS seeks to support flexibility and efficiency in Medicare Advantage and Part D plans.
Hypercalcemia Pharmacotherapy: A Review
Depending on your practice environment, you may not regularly encounter hypercalcemia.
A Must-Read Protocol to Help Pharmacists Prepare for Interviews: Part 2
The competition for positions in the world of pharmacy is fierce.
AMCP Applauds Introduction of the "Pharmaceutical Information Exchange (PIE) Act of 2017"
Patient Satisfaction – The True Differentiator for Specialty Pharmacies
A growing number of specialty pharmacy contractual agreements with payers and manufacturers have patient satisfaction metrics built in.
Study: Patients Forgo EpiPen Treatment Due to High Cost
Annual out-of-pocket spending on EpiPen increased 124% since 2007, according to a recent study.
Thirteen Indicted in Pill Mill and Health Care Fraud Scheme
The indictments contain a combined 477 charges that include counts of money laundering, health care fraud, and unlawfully selling prescriptions of controlled substances.
Clinical Therapy Management Boosts Patient Outcomes
Optimized program can boost adherence and improve reporting capabilities to manufacturers.
Infamous Inmate Mumia Abu-Jamal To Receive Treatment for Hepatitis C
After a prolonged court battle, Abu-Jamal will begin treatment for HCV in prison.
CMS Finalizes 2018 Medicare Advantage, Part D Programs
New policy updates support flexibility and efficiency in Medicare Advantage and Part D plans.
Experimental Compound Reduces Glucose Production in Type 2 Diabetes
Compound may help patients with type 2 diabetes better control glucose levels.
Injectable Implant May be the Future of HIV Prevention
Novel drug delivery system steadily releases preventive HIV drugs over an extended period of time.